+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Malignant Pleural Mesothelioma - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant Pleural Mesothelioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Castleman Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Castleman Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Central Nervous System Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Central Nervous System Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2024 - Product Thumbnail Image

Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cancer Therapy Related Diarrhea - Pipeline Insight, 2024 - Product Thumbnail Image

Cancer Therapy Related Diarrhea - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2024 - Product Thumbnail Image

Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Sezary Syndrome - Pipeline Insghts, 2024 - Product Thumbnail Image

Sezary Syndrome - Pipeline Insghts, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Minimal Residual Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Minimal Residual Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Hodgkin's Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Hodgkin's Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insight, 2024 - Product Thumbnail Image

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
High-Grade Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

High-Grade Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
Malt Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Malt Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
FYARRO Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

FYARRO Market Size, Forecast, and Market Insight - 2032

  • Report
  • March 2024
  • 30 Pages
  • Global
From
From
CDK12 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CDK12 Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • March 2024
  • 60 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more